nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—SRD5A1—polycystic ovary syndrome	0.819	1	CbGaD
Finasteride—Dutasteride—SRD5A1—polycystic ovary syndrome	0.00368	0.446	CrCbGaD
Finasteride—Dydrogesterone—PGR—polycystic ovary syndrome	0.000766	0.0929	CrCbGaD
Finasteride—Drostanolone—SHBG—polycystic ovary syndrome	0.000518	0.0628	CrCbGaD
Finasteride—Testosterone Propionate—CYP17A1—polycystic ovary syndrome	0.000456	0.0552	CrCbGaD
Finasteride—Drostanolone—AR—polycystic ovary syndrome	0.000454	0.055	CrCbGaD
Finasteride—Drostanolone—CYP19A1—polycystic ovary syndrome	0.00038	0.0461	CrCbGaD
Finasteride—Medrysone—NR3C1—polycystic ovary syndrome	0.00029	0.0351	CrCbGaD
Finasteride—Testosterone Propionate—AR—polycystic ovary syndrome	0.000277	0.0336	CrCbGaD
Finasteride—Progesterone—CYP17A1—polycystic ovary syndrome	0.000209	0.0253	CrCbGaD
Finasteride—Testosterone—CYP11A1—polycystic ovary syndrome	0.000195	0.0236	CrCbGaD
Finasteride—Progesterone—PGR—polycystic ovary syndrome	0.000155	0.0188	CrCbGaD
Finasteride—Progesterone—SHBG—polycystic ovary syndrome	0.000145	0.0176	CrCbGaD
Finasteride—Testosterone—SHBG—polycystic ovary syndrome	0.000137	0.0166	CrCbGaD
Finasteride—Progesterone—AR—polycystic ovary syndrome	0.000127	0.0154	CrCbGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000121	0.000698	CbGpPWpGaD
Finasteride—Testosterone—AR—polycystic ovary syndrome	0.00012	0.0146	CrCbGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000119	0.000689	CbGpPWpGaD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000119	0.000688	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—HMMR—polycystic ovary syndrome	0.000118	0.000684	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—STAR—polycystic ovary syndrome	0.000118	0.000684	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—HMMR—polycystic ovary syndrome	0.000118	0.000684	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000117	0.000676	CbGpPWpGaD
Finasteride—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.000117	0.000675	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000113	0.000653	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000113	0.000653	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000112	0.000645	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000112	0.000645	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000111	0.000641	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000108	0.000626	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000107	0.000617	CbGpPWpGaD
Finasteride—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.000106	0.000614	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000106	0.000613	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000106	0.000612	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000106	0.000612	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—HMMR—polycystic ovary syndrome	0.000106	0.00061	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—LHB—polycystic ovary syndrome	0.000103	0.000595	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—LHB—polycystic ovary syndrome	0.000103	0.000595	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000101	0.000582	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000101	0.000582	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000101	0.000582	CbGpPWpGaD
Finasteride—Testosterone—CYP19A1—polycystic ovary syndrome	0.000101	0.0122	CrCbGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.96e-05	0.000575	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—SULT2A1—polycystic ovary syndrome	9.9e-05	0.000572	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	9.79e-05	0.000566	CbGpPWpGaD
Finasteride—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	9.77e-05	0.000565	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	9.76e-05	0.000564	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—AKR1C1—polycystic ovary syndrome	9.75e-05	0.000563	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—AKR1C1—polycystic ovary syndrome	9.75e-05	0.000563	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.44e-05	0.000545	CbGpPWpGaD
Finasteride—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	9.4e-05	0.000543	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—LHB—polycystic ovary syndrome	9.18e-05	0.000531	CbGpPWpGaD
Finasteride—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	9.03e-05	0.000522	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	9e-05	0.00052	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SULT2A1—polycystic ovary syndrome	8.98e-05	0.000519	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SULT2A1—polycystic ovary syndrome	8.98e-05	0.000519	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—HSD3B2—polycystic ovary syndrome	8.98e-05	0.000519	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	8.78e-05	0.000507	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.77e-05	0.000507	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	8.73e-05	0.000504	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—RRM2—polycystic ovary syndrome	8.69e-05	0.000502	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—RRM2—polycystic ovary syndrome	8.69e-05	0.000502	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—AKR1C1—polycystic ovary syndrome	8.69e-05	0.000502	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.65e-05	0.0005	CbGpPWpGaD
Finasteride—Progesterone—NR3C1—polycystic ovary syndrome	8.62e-05	0.0104	CrCbGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	8.61e-05	0.000498	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—YAP1—polycystic ovary syndrome	8.38e-05	0.000484	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—YAP1—polycystic ovary syndrome	8.38e-05	0.000484	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	8.17e-05	0.000472	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP17A1—polycystic ovary syndrome	8.15e-05	0.000471	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—NAMPT—polycystic ovary syndrome	8.05e-05	0.000465	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—NAMPT—polycystic ovary syndrome	8.05e-05	0.000465	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	8.04e-05	0.000464	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8e-05	0.000462	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8e-05	0.000462	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SULT2A1—polycystic ovary syndrome	8e-05	0.000462	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP11A1—polycystic ovary syndrome	7.95e-05	0.000459	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.95e-05	0.000459	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.89e-05	0.000456	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.89e-05	0.000456	CbGpPWpGaD
Finasteride—Progesterone—CYP1A1—polycystic ovary syndrome	7.83e-05	0.00949	CrCbGaD
Finasteride—AKR1D1—Metabolism—RRM2—polycystic ovary syndrome	7.75e-05	0.000448	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	7.67e-05	0.000443	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—AKR1C3—polycystic ovary syndrome	7.51e-05	0.000434	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.51e-05	0.000434	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—YAP1—polycystic ovary syndrome	7.47e-05	0.000432	CbGpPWpGaD
Finasteride—Testosterone—CYP1A1—polycystic ovary syndrome	7.4e-05	0.00897	CrCbGaD
Finasteride—SRD5A1—Metabolism—CYP17A1—polycystic ovary syndrome	7.39e-05	0.000427	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.39e-05	0.000427	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	7.3e-05	0.000422	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NAMPT—polycystic ovary syndrome	7.18e-05	0.000415	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—SULT2A1—polycystic ovary syndrome	7.16e-05	0.000413	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.13e-05	0.000412	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP11A1—polycystic ovary syndrome	7.09e-05	0.000409	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	7.08e-05	0.000409	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	7.06e-05	0.000408	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.04e-05	0.000406	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	6.84e-05	0.000395	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	6.75e-05	0.00039	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—AKR1C3—polycystic ovary syndrome	6.69e-05	0.000387	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP17A1—polycystic ovary syndrome	6.59e-05	0.000381	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	6.51e-05	0.000376	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.45e-05	0.000373	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	6.41e-05	0.00037	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—TH—polycystic ovary syndrome	6.4e-05	0.00037	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—TH—polycystic ovary syndrome	6.4e-05	0.00037	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.36e-05	0.000368	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	6.36e-05	0.000368	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	6.34e-05	0.000366	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	6.28e-05	0.000363	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	6.25e-05	0.000361	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	6.23e-05	0.00036	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—SLC2A4—polycystic ovary syndrome	6.22e-05	0.000359	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.22e-05	0.000359	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	5.9e-05	0.000341	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	5.89e-05	0.00034	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.85e-05	0.000338	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP19A1—polycystic ovary syndrome	5.85e-05	0.000338	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	5.81e-05	0.000336	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—TH—polycystic ovary syndrome	5.7e-05	0.000329	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	5.55e-05	0.00032	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—SLC2A4—polycystic ovary syndrome	5.55e-05	0.00032	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	5.28e-05	0.000305	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GNAS—polycystic ovary syndrome	5.22e-05	0.000302	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GNAS—polycystic ovary syndrome	5.22e-05	0.000302	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP19A1—polycystic ovary syndrome	5.21e-05	0.000301	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.2e-05	0.0003	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	5.16e-05	0.000298	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.13e-05	0.000296	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	5.03e-05	0.000291	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	5.02e-05	0.00029	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—NCOR1—polycystic ovary syndrome	4.97e-05	0.000287	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—NCOR1—polycystic ovary syndrome	4.97e-05	0.000287	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	4.97e-05	0.000287	CbGpPWpGaD
Finasteride—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	4.83e-05	0.000279	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP1A1—polycystic ovary syndrome	4.72e-05	0.000272	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.72e-05	0.000272	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	4.66e-05	0.000269	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GNAS—polycystic ovary syndrome	4.65e-05	0.000269	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	4.6e-05	0.000266	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NMNAT3—polycystic ovary syndrome	4.57e-05	0.000264	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NCOR1—polycystic ovary syndrome	4.43e-05	0.000256	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—MTHFR—polycystic ovary syndrome	4.4e-05	0.000254	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—MTHFR—polycystic ovary syndrome	4.4e-05	0.000254	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP1A1—polycystic ovary syndrome	4.2e-05	0.000243	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SUOX—polycystic ovary syndrome	4.18e-05	0.000242	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—LPCAT2—polycystic ovary syndrome	4.18e-05	0.000242	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	4.08e-05	0.000236	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	4.06e-05	0.000234	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	4e-05	0.000231	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—MTHFR—polycystic ovary syndrome	3.92e-05	0.000226	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—ISYNA1—polycystic ovary syndrome	3.89e-05	0.000225	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—POMC—polycystic ovary syndrome	3.88e-05	0.000224	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.76e-05	0.000217	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.71e-05	0.000214	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	3.57e-05	0.000206	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—PPARG—polycystic ovary syndrome	3.56e-05	0.000206	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—PPARG—polycystic ovary syndrome	3.56e-05	0.000206	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—POMC—polycystic ovary syndrome	3.52e-05	0.000203	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—POMC—polycystic ovary syndrome	3.52e-05	0.000203	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—INS—polycystic ovary syndrome	3.5e-05	0.000202	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—INS—polycystic ovary syndrome	3.5e-05	0.000202	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	3.33e-05	0.000192	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AKR1C2—polycystic ovary syndrome	3.31e-05	0.000191	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TEAD2—polycystic ovary syndrome	3.31e-05	0.000191	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	3.31e-05	0.000191	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	3.29e-05	0.00019	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	3.28e-05	0.00019	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—PPARG—polycystic ovary syndrome	3.18e-05	0.000184	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—POMC—polycystic ovary syndrome	3.13e-05	0.000181	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—INS—polycystic ovary syndrome	3.12e-05	0.00018	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	3.03e-05	0.000175	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	3.02e-05	0.000175	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	3.02e-05	0.000175	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	2.95e-05	0.00017	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	2.91e-05	0.000168	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	2.81e-05	0.000162	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	2.8e-05	0.000162	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PNPLA2—polycystic ovary syndrome	2.77e-05	0.00016	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	2.74e-05	0.000159	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.74e-05	0.000158	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.7e-05	0.000156	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SRD5A1—polycystic ovary syndrome	2.63e-05	0.000152	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—STAR—polycystic ovary syndrome	2.51e-05	0.000145	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.45e-05	0.000142	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	2.39e-05	0.000138	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	2.39e-05	0.000138	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HMMR—polycystic ovary syndrome	2.23e-05	0.000129	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.17e-05	0.000125	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.14e-05	0.000124	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HSD3B1—polycystic ovary syndrome	2.13e-05	0.000123	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	2e-05	0.000116	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—LHB—polycystic ovary syndrome	1.94e-05	0.000112	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—HSD3B2—polycystic ovary syndrome	1.9e-05	0.00011	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	1.9e-05	0.00011	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	1.84e-05	0.000106	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	1.81e-05	0.000105	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.75e-05	0.000101	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.72e-05	9.96e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	1.69e-05	9.78e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	1.64e-05	9.47e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	1.61e-05	9.33e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	1.58e-05	9.13e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	1.54e-05	8.9e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.54e-05	8.88e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	1.52e-05	8.77e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	1.5e-05	8.66e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	1.42e-05	8.18e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.41e-05	8.12e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.41e-05	8.12e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	1.4e-05	8.11e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	1.39e-05	8.05e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	1.37e-05	7.93e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	1.33e-05	7.68e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.31e-05	7.55e-05	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.3e-05	7.53e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	1.22e-05	7.07e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—TH—polycystic ovary syndrome	1.21e-05	6.97e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	1.19e-05	6.85e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	1.17e-05	6.78e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	1.14e-05	6.6e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.11e-05	6.42e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.11e-05	6.42e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	1.1e-05	6.37e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	1.1e-05	6.34e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	1.08e-05	6.26e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	1.02e-05	5.91e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	1.01e-05	5.82e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	9.85e-06	5.69e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	9.38e-06	5.42e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.31e-06	5.38e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	8.89e-06	5.14e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.83e-06	5.1e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—TH—polycystic ovary syndrome	8.72e-06	5.04e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	8.48e-06	4.9e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.42e-06	4.87e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	8.29e-06	4.79e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	7.98e-06	4.61e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.51e-06	4.34e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.16e-06	4.14e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	7.12e-06	4.11e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	6.78e-06	3.92e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	6.72e-06	3.88e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	6.63e-06	3.83e-05	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—INS—polycystic ovary syndrome	6.59e-06	3.81e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.53e-06	3.77e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	6.43e-06	3.71e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.38e-06	3.69e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.18e-06	3.57e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	5.99e-06	3.46e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.69e-06	3.29e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.51e-06	3.18e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.31e-06	3.07e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.1e-06	2.95e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.04e-06	2.91e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	4.86e-06	2.81e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	4.79e-06	2.77e-05	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—INS—polycystic ovary syndrome	4.77e-06	2.75e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.76e-06	2.75e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.69e-06	2.71e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.05e-06	2.34e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.94e-06	2.28e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.71e-06	2.14e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.31e-06	1.91e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.15e-06	1.82e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.99e-06	1.73e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.79e-06	1.61e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.26e-06	1.31e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.23e-06	1.29e-05	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.22e-06	1.28e-05	CbGpPWpGaD
